Isreali researchers develop new method for cancer screening
A new method for early and accurate breast cancer screening has been developed by
Isreali researchers at Ben-Gurion University of the Negev and Soroka University Medical Centre, using commercially available technology. The researchers were able to isolate relevant data to more accurately identify breast cancer biomarkers using two different electronic nose gas sensors for breath, along with gas-chromatography mass spectrometry (GC-MS) to quantify substances found in urine. Researchers detected breast cancer with more than 95 per cent average accuracy using an inexpensive commercial electronic nose (e-nose) that identifies unique breath patterns in women with breast cancer. In addition, their revamped statistical analyses of urine samples submitted both by healthy patients and those diagnosed with breast cancer yielded 85 per cent average accuracy.